Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial
Rakesh Popat,
Dana Warcel,
Jenny O’Nions,
Anna Cowley,
Sasha Smith,
William R Tucker,
Kwee Yong,
Simona Degli Esposti
Affiliations
Rakesh Popat
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
Dana Warcel
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
Jenny O’Nions
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
Anna Cowley
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
Sasha Smith
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
William R Tucker
National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK
Kwee Yong
National Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Foundation Trust
Simona Degli Esposti
National Institute for Health Research Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital NHS Foundation Trust & University College London Institute of Ophthalmology, London, UK
